MaaT Pharma SA (4RD.F)

7.52 -0.22 (-2.84%) As of 03:29PM CEST. Market open.

MaaT Pharma SA

70 Avenue Tony Garnier
Lyon 69007
France
33 4 28 29 14 00
https://www.maatpharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 52

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Herve Affagard	CEO, Co-Founder & Director	271.2k	N/A	1975
Dr. Joel Dore Ph.D.	Co-Founder & Member of Scientific Advisory Board	N/A	N/A	N/A
Mr. Pierre Rimbaud	Co-Founder	N/A	N/A	N/A
Ms. Sian Crouzet	Chief Financial Officer	N/A	N/A	N/A
Ms. Carole Schwintner	Chief Technology Officer	N/A	N/A	N/A
Dr. Nathalie Corvaia Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Guilhaume Debroas Ph.D.	Head of Investor Relations	N/A	N/A	N/A
Dr. Emilie Plantamura	Head of Clinical Development	N/A	N/A	N/A
Mr. Jonathan Chriqui Pharm.D.	Chief Business Officer	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.

Corporate Governance

MaaT Pharma SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.